IMAX (IMAX) to Post Quarterly Earnings on Wednesday

IMAX (NYSE:IMAX) is anticipated to issue its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect the company to announce earnings of $0.43 per share and revenue of $120.2970 million for the quarter. Individuals may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Wednesday, February 25, 2026 at 4:30 PM ET.

IMAX Price Performance

Shares of NYSE:IMAX opened at $37.95 on Wednesday. The business’s fifty day moving average price is $36.34 and its two-hundred day moving average price is $33.35. IMAX has a fifty-two week low of $20.48 and a fifty-two week high of $39.98. The stock has a market capitalization of $2.04 billion, a price-to-earnings ratio of 53.45, a price-to-earnings-growth ratio of 1.78 and a beta of 0.38.

Institutional Investors Weigh In On IMAX

A number of institutional investors have recently made changes to their positions in the stock. CIBC Private Wealth Group LLC acquired a new position in IMAX in the third quarter valued at about $27,000. Quarry LP increased its stake in shares of IMAX by 166.8% in the 4th quarter. Quarry LP now owns 875 shares of the company’s stock valued at $32,000 after acquiring an additional 547 shares during the last quarter. Caitong International Asset Management Co. Ltd increased its stake in shares of IMAX by 2,310.4% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,157 shares of the company’s stock valued at $38,000 after acquiring an additional 1,109 shares during the last quarter. Aster Capital Management DIFC Ltd raised its position in shares of IMAX by 863.0% in the 4th quarter. Aster Capital Management DIFC Ltd now owns 1,666 shares of the company’s stock valued at $62,000 after acquiring an additional 1,493 shares during the period. Finally, Kestra Advisory Services LLC bought a new position in IMAX during the 4th quarter worth approximately $74,000. 93.51% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts have weighed in on IMAX shares. Weiss Ratings reaffirmed a “buy (b)” rating on shares of IMAX in a research note on Monday, December 29th. Roth Mkm reaffirmed a “buy” rating and set a $42.00 price target on shares of IMAX in a report on Monday, December 8th. Benchmark reissued a “buy” rating on shares of IMAX in a report on Monday, January 5th. Rosenblatt Securities boosted their target price on shares of IMAX from $42.00 to $47.00 and gave the stock a “buy” rating in a research note on Monday, December 8th. Finally, Macquarie Infrastructure upped their target price on shares of IMAX from $39.00 to $44.00 and gave the stock an “outperform” rating in a research report on Thursday, January 15th. Ten equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $42.70.

About IMAX

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.